Mimedx (MDXG) Gains from Investment Securities (2010 - 2026)
Mimedx recorded quarterly Gains from Investment Securities of $1.9 million in Q1 2026, down 38.68% quarter-over-quarter from $3.1 million in Q4 2025, and down 22.66% year-over-year from $2.5 million in Q1 2025.
Mimedx's Gains from Investment Securities history runs 15 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 22.66% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $2.5 million (up 639.24% YoY), while the FY2025 annual figure was $3.1 million, up 8057.89% from the prior year.
- Gains from Investment Securities came in at $1.9 million for Q1 2026 at Mimedx, down from $3.1 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $3.1 million in Q4 2025 to a low of -$2.5 million in Q3 2024.
- A 5-year average of $537785.7 and a median of $240500.0 in 2023 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities surged 16914.29% in 2022 and plunged 15618.75% in 2024, its largest moves.
- Mimedx's Gains from Investment Securities stood at $1.1 million in 2022, then sank by 88.18% to $132000.0 in 2023, then tumbled by 84.85% to $20000.0 in 2024, then jumped by 15400.0% to $3.1 million in 2025, then sank by 38.68% to $1.9 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.9 million, $3.1 million, and -$2.5 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.90 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Jun 30, 2025 | -2.46 Mn |
| Jun 30, 2025 | -2.46 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | -2.48 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Jun 30, 2024 | 349,000.00 |
| Jun 30, 2024 | 349,000.00 |
| Mar 31, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 132,000.00 |
| Dec 31, 2023 | 132,000.00 |
| Sep 30, 2023 | 16,000.00 |
| Sep 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Dec 31, 2022 | 1.12 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 14,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 1.19 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | -26,000.00 |
| Dec 31, 2021 | -26,000.00 |
| Sep 30, 2021 | -4.80 Mn |
| Sep 30, 2021 | -4.80 Mn |
| Jun 30, 2021 | 4.56 Mn |
| Jun 30, 2021 | 4.56 Mn |
| Mar 31, 2021 | 7,000.00 |
| Mar 31, 2021 | 7,000.00 |
| Dec 31, 2020 | -75,000.00 |
| Dec 31, 2020 | -75,000.00 |
| Sep 30, 2020 | 79,000.00 |
| Sep 30, 2020 | 79,000.00 |
| Jun 30, 2020 | 792,000.00 |
| Jun 30, 2020 | 792,000.00 |
| Mar 31, 2020 | 1.54 Mn |
| Mar 31, 2020 | 1.54 Mn |
| Dec 31, 2019 | 318,000.00 |
| Dec 31, 2019 | 318,000.00 |
| Sep 30, 2019 | -1.43 Mn |
| Sep 30, 2019 | -1.43 Mn |
| Jun 30, 2019 | 1.11 Mn |
| Jun 30, 2019 | 1.11 Mn |
| Mar 31, 2019 | -1,000.00 |
| Mar 31, 2019 | -1,000.00 |
| Dec 31, 2018 | 285,000.00 |
| Dec 31, 2018 | 285,000.00 |
| Sep 30, 2018 | 225,000.00 |
| Sep 30, 2018 | 225,000.00 |
| Jun 30, 2018 | 4.40 Mn |
| Jun 30, 2018 | 4.40 Mn |
| Dec 31, 2017 | -6.90 Mn |
| Dec 31, 2017 | -6.90 Mn |
| Sep 30, 2017 | 12.24 Mn |
| Sep 30, 2017 | 12.24 Mn |
| Jun 30, 2017 | 339,000.00 |
| Jun 30, 2017 | 339,000.00 |
| Mar 31, 2017 | 2.33 Mn |
| Mar 31, 2017 | 2.33 Mn |
| Dec 31, 2016 | 273,000.00 |
| Dec 31, 2016 | 273,000.00 |
| Sep 30, 2016 | 208,000.00 |
| Sep 30, 2016 | 208,000.00 |
| Mar 31, 2016 | 684,000.00 |
| Mar 31, 2016 | 684,000.00 |
| Mar 31, 2013 | 2.65 Mn |
| Mar 31, 2013 | 2.65 Mn |
| Dec 31, 2012 | 635,962.00 |
| Dec 31, 2012 | 635,962.00 |
| Sep 30, 2012 | 12.64 Mn |
| Sep 30, 2012 | 12.64 Mn |
| Jun 30, 2012 | 2.95 Mn |
| Jun 30, 2012 | 2.95 Mn |
| Dec 31, 2011 | 10.33 Mn |
| Dec 31, 2011 | 10.33 Mn |
| Dec 31, 2010 | 8.26 Mn |
| Dec 31, 2010 | 8.26 Mn |